SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 254 filers reported holding SAGE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $80,159,000 | -16.5% | 567,497 | -7.5% | 0.53% | -26.8% |
| Q2 2018 | $96,000,000 | -7.9% | 613,300 | -5.2% | 0.72% | -18.3% |
| Q1 2018 | $104,185,000 | +2.6% | 646,828 | +4.9% | 0.88% | +0.3% |
| Q4 2017 | $101,546,000 | +302.0% | 616,514 | +52.0% | 0.88% | +329.3% |
| Q3 2017 | $25,262,000 | +52.3% | 405,485 | +94.6% | 0.20% | +41.4% |
| Q2 2017 | $16,591,000 | +12.1% | 208,328 | 0.0% | 0.14% | +19.8% |
| Q1 2017 | $14,806,000 | +39.2% | 208,328 | 0.0% | 0.12% | +16.3% |
| Q4 2016 | $10,637,000 | +10.9% | 208,328 | 0.0% | 0.10% | +19.5% |
| Q3 2016 | $9,594,000 | +42.1% | 208,328 | -7.0% | 0.09% | +22.5% |
| Q2 2016 | $6,751,000 | -6.0% | 224,048 | 0.0% | 0.07% | -6.6% |
| Q1 2016 | $7,183,000 | +17.3% | 224,048 | +113.4% | 0.08% | +49.0% |
| Q4 2015 | $6,122,000 | +37.8% | 105,000 | 0.0% | 0.05% | +24.4% |
| Q3 2015 | $4,444,000 | -42.0% | 105,000 | 0.0% | 0.04% | -38.8% |
| Q2 2015 | $7,665,000 | +103.5% | 105,000 | +40.0% | 0.07% | +116.1% |
| Q1 2015 | $3,767,000 | +37.2% | 75,000 | 0.0% | 0.03% | +10.7% |
| Q4 2014 | $2,745,000 | +16.2% | 75,000 | 0.0% | 0.03% | -6.7% |
| Q3 2014 | $2,363,000 | – | 75,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |